Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: Association with microalbuminuria and silent coronary artery disease

Diabetes and Metabolism

Volumn 37, Issue 4, 2011, Pages 343-350

  Nguyen, M T ^a   Cosson, E ^a   Valensi, P ^a   Poignard, P ^b   Nitenberg, A ^b   Pham, I ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

Diabetes mellitus; Left ventricular function; Microalbuminuria; Silent coronary artery disease; Silent myocardial ischaemia; Transthoracic echocardiography; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART SCINTISCANNING; HUMAN; HYPERTENSION; IMAGING SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; SCREENING; SILENT MYOCARDIAL INFARCTION; SILENT MYOCARDIAL ISCHEMIA; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER;

AGED; ALBUMINURIA; ASYMPTOMATIC DISEASES; CARDIOMYOPATHY, DILATED; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GREAT BRITAIN; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80053132377     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.12.006     Document Type: Article

References (24)

1. Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: evaluation by Doppler echocardiography. J Am Coll Cardiol 2006, 48:1548-1551.
2. Srivastava P.M., Calafiore P., Macisaac R.J., Patel S.K., Thomas M.C., Jerums G., et al. Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci (Lond) 2008, 114:313-320.
3. Dawson A., Morris A.D., Struthers A.D. The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 2005, 48:1971-1979.
4. Devereux R.B., Roman M.J., Paranicas M., O'Grady M.J., Lee E.T., Welty T.K., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000, 101:2271-2276.
5. Cosson E., Guimfack M., Paries J., Paycha F., Attali J.R., Valensi P. Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?. Diabetes Metab 2003, 29:470-476.
6. Valensi P., Paries J., Brulport-Cerisier V., Torremocha F., Sachs R.N., Vanzetto G., et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care 2005, 28:2722-2727.
7. Cosson E., Guimfack M., Paries J., Paycha F., Attali J.R., Valensi P. Prognosis for coronary stenoses in patients with diabetes and silent myocardial ischemia. Diabetes Care 2003, 26:1313-1314.
8. Nitenberg A., Ledoux S., Valensi P., Sachs R., Attali J.R., Antony I. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes 2001, 50:1180-1185.
9. Valensi P., Sachs R.N., Lormeau B., Taupin J.M., Ouzan J., Blasco A., et al. Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 1997, 23:409-416.
10. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
11. Ganau A., Devereux R.B., Roman M.J., de Simone G., Pickering T.G., Saba P.S., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550-1558.
12. Stevens R.J., Kothari V., Adler A.I., Stratton I.M. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001, 101:671-679.
13. Palmieri V., Bella J., Arnett D., Liu J., Oberman A., Schuck M., et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects. Hypertension Genetic Epidemiology Network (hyperGEN) Study. Circulation 2001, 103:102-107.
14. Liu J.E., Robbins D.C., Palmieri V., Bella J.N., Roman M.J., Fabsitz R., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 2003, 41:2022-2028.
15. Cosson E., Pham I., Valensi P., Paries J., Attali J.R., Nitenberg A. Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries. Diabetes Care 2006, 29:107-112.
16. Aguilar D., Hallman D.M., Piller L.B., Klein B.E., Klein R., Devereux R.B., et al. Adverse association between diabetic retinopathy and cardiac structure and function. Am Heart J 2009, 157:563-568.
17. Fuller J.H., Stevens L.K., Wang S.L. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(Suppl. 2):S54-S64.
18. Marwick T.H., Case C., Sawada S., Vasey C., Short L., Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002, 25:1042-1048.
19. Whellan D.J., Tuttle R.H., Velazquez E.J., Shaw L.K., Jollis J.G., Ellis W., et al. Predicting significant coronary artery disease in patients with left ventricular dysfunction. Am Heart J 2006, 152:340-347.
20. Puel J., Valensi P., Vanzetto G., Lassmann-Vague V., Monin J.L., Moulin P., et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004, 30:3S-18S.
21. Bax J.J., Young L.H., Frye R.L., Bonow R.O., Steinberg H.O., Barrett E.J. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007, 30:2729-2736.
22. Young L.H., Wackers F.J., Chyun D.A., Davey J.A., Barrett E.J., Taillefer R., et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 2009, 301:1547-1555.
23. Sorajja P., Chareonthaitawee P., Rajagopalan N., Miller T.D., Frye R.L., Hodge D.O., et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation 2005, 112(suppl I):I-311.
24. Faglia E., Manuela M., Antonella Q., Michela G., Vincenzo C., Maurizio C., et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 2005, 149:e1-e6.